drugset / Trial / NCT02325583

Intraoral 30% Glucose Effect In Newborns

NCT02325583

Phase 3 Completed 19 enrolled Baskent University
NaSingle-groupOpen-labelSupportive care

Summary

Newborn often sedated during MRI but sedation itself creates adverse events and management is more challenging in the MR environment. The investigators describe the investigators initial experience with oral 30% glucose administration through a pacifier during MRI for imaging of newborns. Using this technique, majority of newborns can complete MRI examination without the need for sedation and also offers the availability of administering sedatives to unsuccessful patients.

Timeline

Start
2014-01
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Glucose Unknown 2 ml Oral
Background Midazolam Small molecule 0.1 mg/kg Intravenous

Indications